Chembio diagnostics, inc. (CEMI)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
REVENUES:
TOTAL REVENUES

32,781

34,464

36,173

36,277

35,406

34,581

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net product sales

-

-

-

-

-

-

-

-

-

-

-

-

13,190

13,680

14,194

17,901

22,189

21,886

24,695

25,733

26,660

25,949

26,496

28,293

26,106

27,515

27,827

23,527

24,277

24,327

22,825

23,607

20,770

17,422

15,302

2,345,441

0

0

0

License and royalty revenue

-

-

-

-

-

-

-

-

-

-

-

-

527

449

152

83

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

140

187

317,634

0

0

0

R&D, milestone and grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

3,874

3,739

3,688

3,180

2,368

2,316

2,193

1,592

1,372

1,672

1,893

2,408

2,572

2,028

1,726

1,417

1,358

1,283

1,120

1,228

1,523

1,825

2,186

1,098,121

0

0

0

License and Maintenance Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

0

0

-

-

0

-

-

-

-

-

-

-

-

TOTAL REVENUES

-

-

-

-

-

-

-

-

-

-

-

-

17,592

17,868

18,034

21,175

24,625

24,255

26,929

27,356

28,063

27,645

28,410

30,713

28,684

29,549

29,555

24,945

25,635

25,610

23,960

24,875

22,405

19,388

17,676

3,761,196

0

0

0

GROSS MARGIN

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,568

9,526

10,965

-

11,524

11,264

11,228

10,814

11,174

12,580

11,878

12,300

12,188

9,861

10,151

10,789

10,375

11,317

10,796

9,390

8,855

2,101,151

0

0

0

COSTS AND EXPENSES:
Cost of product revenue

21,757

22,394

25,577

24,863

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sales

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sales

-

-

-

-

-

-

-

-

-

-

-

-

9,201

9,417

9,466

11,648

13,659

13,768

15,405

16,092

16,835

16,831

17,235

18,133

16,805

17,249

17,366

15,083

15,484

14,820

13,585

13,558

11,608

9,997

8,820

1,660,045

0

0

0

Research and development expenses

8,279

8,538

9,332

9,006

8,896

8,526

8,256

8,164

8,155

8,555

8,196

8,654

9,039

8,427

7,731

7,038

6,427

6,377

6,305

5,707

5,219

4,832

5,124

5,754

5,986

5,834

5,270

4,674

4,152

4,486

4,544

4,781

4,967

4,878

4,927

795,281

0

0

0

Selling, general and administrative expenses

16,281

16,138

15,678

14,257

12,707

11,100

10,048

9,319

8,881

8,963

9,067

8,595

8,084

7,595

7,036

7,123

7,684

7,663

8,244

8,264

8,051

7,531

7,103

6,543

5,756

5,461

5,032

4,860

4,779

4,851

4,532

4,273

3,882

3,424

3,214

682,279

0

0

0

Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Also includes other related costs.

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition costs

389

721

733

733

733

337

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL COSTS AND EXPENSES

47,431

47,792

50,012

47,158

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL COSTS AND EXPENSES

-

-

-

-

-

-

-

-

30,915

30,497

36,170

32,090

29,761

25,440

28,536

27,930

27,881

27,809

14,549

13,972

13,271

12,364

12,228

12,297

11,743

11,295

10,302

9,534

8,932

9,337

9,077

9,055

8,850

8,302

8,142

1,477,560

0

0

0

LOSS FROM OPERATIONS

-14,649

-13,328

-13,247

-11,970

-10,424

-7,982

-6,822

-5,080

-5,507

-6,482

-6,971

-8,527

-8,732

-7,571

-6,199

-4,634

-3,146

-3,554

-3,024

-2,708

-2,043

-1,550

-1,054

282

135

1,004

1,885

326

1,218

1,452

1,297

2,262

1,946

1,087

713

623,590

0

0

0

OTHER EXPENSE:
Interest (expense) income, net

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) gain on sale of fixed asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Interest income, net

-

-

-

34

-

-

-

28

11

22

40

42

36

25

10

4

3

2

3

3

5

5

6

6

6

5

6

7

7

7

7

6

6

6

5

622

0

0

0

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

0

-

0

0

-

0

2

5

7

9

12

14

16

18

19

2,071

0

0

0

TOTAL OTHER INCOME

-

-

-

-

-

-

-

-

-

-

-

-

36

25

9

3

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL OTHER INCOME (EXPENSES)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

1

13

12

11

9

0

-1

-5

-8

-10

-12

-17

-1,453

0

0

0

LOSS BEFORE INCOME TAXES

-16,165

-14,175

-13,424

-11,935

-10,369

-7,933

-6,781

-5,052

-5,496

-6,460

-6,931

-8,484

-8,696

-7,546

-6,194

-4,635

-3,148

-3,557

-3,022

-2,704

-2,043

-1,550

-1,053

283

149

1,017

1,897

336

1,219

1,450

1,292

2,253

1,936

1,075

696

622,137

0

0

0

Income tax (benefit)

-307

-500

-467

-447

-339

-67

-88

-88

-88

-88

0

0

5,962

5,800

5,243

5,101

-1,094

-1,160

-778

-626

-484

-412

-149

199

160

486

612

60

394

509

-4,838

-4,644

-4,847

-5,133

0

0

0

0

0

NET LOSS

-15,858

-13,675

-12,956

-11,488

-10,029

-7,865

-6,693

-4,963

-5,408

-6,371

-6,931

-8,484

-14,659

-13,347

-11,438

-9,737

-2,053

-2,397

-2,243

-2,077

-1,559

-1,137

-903

83

-11

530

1,284

275

824

941

6,130

6,898

6,784

6,208

696

622,137

0

0

0

Basic loss per share (in dollars per share)

-0.29

-0.24

-0.22

-0.19

-0.16

-0.21

-0.16

-0.12

-0.05

-0.16

-0.05

-0.18

-0.13

-0.18

-0.19

-0.86

-0.03

-0.06

-0.05

-0.07

-0.07

-0.05

-0.03

-0.02

-0.02

-0.03

0.08

-0.03

0.04

0.07

-0.04

0.04

0.05

0.71

0.06

0.02

0.00

0.00

0.01

Diluted loss per share (in dollars per share)

-0.29

-0.24

-0.22

-0.19

-0.16

-0.21

-0.16

-0.12

-0.05

-0.16

-0.05

-0.18

-0.13

-0.18

-0.19

-0.86

-0.03

-0.06

-0.05

-0.07

-0.07

-0.05

-0.03

-0.02

-0.02

-0.02

0.07

-0.03

0.04

0.06

-0.04

0.04

0.05

0.65

0.06

0.02

0.00

0.00

0.01

Weighted average number of shares outstanding, basic (in shares)

17,197

16,812

16,923

16,914

17,166

16,123

14,173

14,165

13,267

12,319

12,311

12,299

12,270

12,048

11,142

9,667

9,631

9,623

9,628

9,627

9,624

9,615

9,611

9,555

9,339

9,329

9,324

9,259

8,062

8,021

8,001

7,987

7,934

-46,581

7,913

7,882

62,284

62,146

62,070

Weighted average number of shares outstanding, diluted (in shares)

17,197

16,812

16,923

16,914

17,166

16,123

14,173

14,165

13,267

12,319

12,311

12,299

12,270

12,048

11,142

9,667

9,631

9,623

9,628

9,627

9,624

9,615

9,611

9,555

9,339

10,297

9,824

9,259

8,699

9,420

8,001

8,525

8,512

-45,284

8,508

8,716

62,284

67,264

69,250

Net Product Revenue [Member]
TOTAL REVENUES

27,937

28,844

29,975

29,769

28,139

27,913

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue earned during the period from research and development milestones when those milestones are reached and non-milestone contracts and grants when earned.
TOTAL REVENUES

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and Royalty Revenue [Member]
TOTAL REVENUES

957

938

945

935

963

948

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-